Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serial Llama Immunization with Various SARS-CoV-2 RBD Variants Induces Broad Spectrum Virus-Neutralizing Nanobodies.
Solodkov PP, Najakshin AM, Chikaev NA, Kulemzin SV, Mechetina LV, Baranov KO, Guselnikov SV, Gorchakov AA, Belovezhets TN, Chikaev AN, Volkova OY, Markhaev AG, Kononova YV, Alekseev AY, Gulyaeva MA, Shestopalov AM, Taranin AV. Solodkov PP, et al. Among authors: belovezhets tn. Vaccines (Basel). 2024 Jan 26;12(2):129. doi: 10.3390/vaccines12020129. Vaccines (Basel). 2024. PMID: 38400113 Free PMC article.
Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection.
Kulemzin SV, Guselnikov SV, Nekrasov BG, Molodykh SV, Kuvshinova IN, Murasheva SV, Belovezhets TN, Gorchakov AA, Chikaev AN, Chikaev NA, Volkova OY, Yurina AA, Najakshin AM, Taranin AV. Kulemzin SV, et al. Among authors: belovezhets tn. Vaccines (Basel). 2024 Jan 6;12(1):55. doi: 10.3390/vaccines12010055. Vaccines (Basel). 2024. PMID: 38250868 Free PMC article.
Humoral Immune Responses in Patients with Severe COVID-19: A Comparative Pilot Study between Individuals Infected by SARS-CoV-2 during the Wild-Type and the Delta Periods.
Sukhova M, Byazrova M, Mikhailov A, Yusubalieva G, Maslova I, Belovezhets T, Chikaev N, Vorobiev I, Baklaushev V, Filatov A. Sukhova M, et al. Among authors: belovezhets t. Microorganisms. 2023 Sep 20;11(9):2347. doi: 10.3390/microorganisms11092347. Microorganisms. 2023. PMID: 37764191 Free PMC article.
Corrigendum: Highly invasive fluorescent/bioluminescent patient-derived orthotopic model of glioblastoma in mice.
Yuzhakova D, Kiseleva E, Shirmanova M, Shcheslavskiy V, Sachkova D, Snopova L, Bederina E, Lukina M, Dudenkova V, Yusubalieva G, Belovezhets T, Matvienko D, Baklaushev V. Yuzhakova D, et al. Among authors: belovezhets t. Front Oncol. 2022 Sep 29;12:1040637. doi: 10.3389/fonc.2022.1040637. eCollection 2022. Front Oncol. 2022. PMID: 36248972 Free PMC article.
Highly Invasive Fluorescent/Bioluminescent Patient-Derived Orthotopic Model of Glioblastoma in Mice.
Yuzhakova D, Kiseleva E, Shirmanova M, Shcheslavskiy V, Sachkova D, Snopova L, Bederina E, Lukina M, Dudenkova V, Yusubalieva G, Belovezhets T, Matvienko D, Baklaushev V. Yuzhakova D, et al. Among authors: belovezhets t. Front Oncol. 2022 Jul 13;12:897839. doi: 10.3389/fonc.2022.897839. eCollection 2022. Front Oncol. 2022. PMID: 35912166 Free PMC article.
14 results